(+)-Cannabidiol analogues which bind cannabinoid receptors but exert peripheral activity only

European Journal of Pharmacology

Volumn 506, Issue 2, 2004, Pages 179-188

  Fride, Ester ^a   Feigin, Cfir ^a   Ponde, Datta E ^b   Breuer, Aviva ^b   Hanuš, Lumír ^b   Arshavsky, Nina ^a   Mechoulam, Raphael ^b  

^a ARIEL UNIVERSITY   (Israel)

^b HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

Cannabidiol; Cannabinoid; Cannabinoid receptor; Intestinal motility; SR141716; SR144528

Indexed keywords

5 (4 CHLORO 3 METHYLPHENYL) 1 (4 METHYLBENZYL) N (1,3,3 TRIMETHYLBICYCLO[2.2.1]HEPTAN 2 YL) 3 PYRAZOLECARBOXAMIDE; 7 CARBOXYCANNABIDIOL; 7 CARBOXYCANNABIDIOL 1,1 DIMETHYLHEPTANE; 7 HYDROXYCANNABIDIOL; 7 HYDROXYCANNABIDIOL 1,1 DIMETHYLHEPTANE; ANALGESIC AGENT; ANTIDIARRHEAL AGENT; ANTIINFLAMMATORY AGENT; ARACHIDONIC ACID; CANNABIDIOL 1,1 DIMETHYLHEPTANE; CANNABIDIOL DERIVATIVE; CANNABINOID 1 RECEPTOR; CANNABINOID 2 RECEPTOR; DRONABINOL; INDOMETACIN; PSYCHOTROPIC AGENT; RIMONABANT; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; DEFECATION; DRUG ACTIVATION; DRUG ACTIVITY; DRUG EFFECT; DRUG INHIBITION; DRUG RECEPTOR BINDING; FEMALE; INTESTINE MOTILITY; KNOCKOUT MOUSE; MOUSE; NONHUMAN; OTITIS; PAIN; PRIORITY JOURNAL;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ARACHIDONIC ACID; CANNABIDIOL; DEFECATION; EAR, EXTERNAL; EDEMA; FEMALE; FORMALDEHYDE; GASTROINTESTINAL MOTILITY; MICE; PERIPHERAL NERVOUS SYSTEM; RECEPTOR, CANNABINOID, CB1; RECEPTORS, CANNABINOID;

EID: 9944240860     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2004.10.049     Document Type: Article

References (35)

1. S. Ben-Shabat, E. Fride, T. Sheskin, T. Tamiri, M.H. Rhee, Z. Vogel, T. Bisogno, L. De Petrocellis, V. Di Marzo, and R. Mechoulam An entourage effect: inactive endogenous fatty acid glycerol esters enhance 2-arachidonoyl-glycerol cannabinoid activity Eur. J. Pharmacol. 353 1998 23 31
2. T. Bisogno, L. Hanus, L. De Petrocellis, S. Tchilibon, D.E. Ponde, I. Brandi, A.S. Moriello, J.B. Davis, R. Mechoulam, and V. Di Marzo Molecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide Br. J. Pharmacol. 134 2001 845 852
3. A. Calignano, G. La Rana, A. Makriyannis, S.Y. Lin, M. Beltramo, and D. Piomelli Inhibition of intestinal motility by anandamide, an endogenous cannabinoid Eur. J. Pharmacol. 340 1997 R7 R8
4. M.A. Casu, A. Porcella, S. Ruiu, P. Saba, G. Marchese, M.A. Carai, R. Reali, G.L. Gessa, and L. Pani Differential distribution of functional cannabinoid CB1 receptors in the mouse gastroenteric tract Eur. J. Pharmacol. 459 2003 97 105
5. G.B. Chesher, C.J. Dahl, M. Everingham, D.M. Jackson, H. Marchant-Williams, and G.A. Starmer The effect of cannabinoids on intestinal motility and their antinociceptive effect in mice Br. J. Pharmacol. 49 1973 588 594
6. G. Colombo, R. Agabio, C. Lobina, R. Reali, and G.L. Gessa Cannabinoid modulation of intestinal propulsion in mice Eur. J. Pharmacol. 344 1998 67 69
7. E. Fride Anandamides: tolerance and cross-tolerance to delta 9-tetrahydrocannabinol Brain Res. 697 1995 83 90
8. E. Fride Endocannabinoids in the central nervous system-an overview Prostaglandins Leukot. Essent. Fat. Acids 66 2002 221 233
9. E. Fride, and R. Mechoulam Pharmacological activity of the cannabinoid receptor agonist, anandamide, a brain constituent Eur. J. Pharmacol. 231 1993 313 314
10. E. Fride, and C. Sanudo-Pena Cannabinoids and endocannabinoids: behavioral and developmental aspects E. Onaivi The Biology of Marijuana 2002 Harwood Academic Publishers Reading 174 204
11. S. Galiegue, S. Mary, J. Marchand, D. Dussossoy, D. Carriere, P. Carayon, M. Bouaboula, D. Shire, G. Le Fur, and P. Casellas Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulations Eur. J. Biochem. 232 1995 54 61
12. A.L. Gardner, S.A. Darroch, L.K. Choo, and F. Mitchelson The effect of some selective agonists and antagonists on peripheral muscarinic receptors Trends Pharmacol. Sci. 1988 40 43 (Suppl.)
13. G. Griffin, S.R. Fernando, R.A. Ross, N.G. McKay, M.L. Ashford, D. Shire, J.W. Huffman, S. Yu, J.A. Lainton, and R.G. Pertwee Evidence for the presence of CB2-like cannabinoid receptors on peripheral nerve terminals Eur. J. Pharmacol. 339 1997 53 61
14. D. Gurwitz, R. Haring, E. Heldman, C.M. Fraser, D. Manor, and A. Fisher Discrete activation of transduction pathways associated with acetylcholine m1 receptor by several muscarinic ligands Eur. J. Pharmacol. 267 1994 21 31
15. W. Haefely, J.R. Martin, and P. Schoch Novel anxiolytics that act as partial agonists at benzodiazepine receptors Trends Pharmacol. Sci. 11 1990 452 456
16. L. Hanus, A. Breuer, S. Tchilibon, S. Shiloah, D. Goldenberg, M. Horowitz, R.G. Pertwee, R.A. Ross, R. Mechoulam, and E. Fride HU-308: a specific agonist for CB(2), a peripheral cannabinoid receptor Proc. Natl. Acad. Sci. U. S. A. 96 1999 14228 14233
17. M. Herkenham Localization of cannabinoid receptors in brain and periphery R.G. Pertwee Cannabinoid Receptors 1995 Academic Press London 145 166
18. A.A. Izzo, N. Mascolo, F. Borrelli, and F. Capasso Defaecation, intestinal fluid accumulation and motility in rodents: implications of cannabinoid CB1 receptors Naunyn-Schmiedeberg's Arch. Pharmacol. 359 1999 65 70
19. A.A. Izzo, N. Mascolo, L. Pinto, R. Capasso, and F. Capasso The role of cannabinoid receptors in intestinal motility, defaecation and diarrhoea in rats Eur. J. Pharmacol. 384 1999 37 42
20. A.A. Izzo, L. Pinto, F. Borrelli, R. Capasso, N. Mascolo, and F. Capasso Central and peripheral cannabinoid modulation of gastrointestinal transit in physiological states or during the diarrhoea induced by croton oil Br. J. Pharmacol. 129 2000 1627 1632
21. A.A. Izzo, R. Capasso, L. Pinto, G. Di Carlo, N. Mascolo, and F. Capasso Effect of vanilloid drugs on gastrointestinal transit in mice Br. J. Pharmacol. 132 2001 1411 1416
22. M. Landi, T. Croci, M. Rinaldi-Carmona, J.P. Maffrand, G. Le Fur, and L. Manara Modulation of gastric emptying and gastrointestinal transit in rats through intestinal cannabinoid CB(1) receptors Eur. J. Pharmacol. 450 2002 77 83
23. A.M. Malfait, R. Gallily, P.F. Sumariwalla, A.S. Malik, E. Andreakos, R. Mechoulam, and M. Feldmann The nonpsychoactive cannabis constituent cannabidiol is an oral anti-arthritic therapeutic in murine collagen-induced arthritis Proc. Natl. Acad. Sci. U. S. A. 97 2000 9561 9566
24. B.R. Martin, D.R. Compton, B.F. Thomas, W.R. Prescott, P.J. Little, R.K. Razdan, M.R. Johnson, L.S. Melvin, R. Mechoulam, and S.J. Ward Behavioral, biochemical, and molecular modeling evaluations of cannabinoid analogs Pharmacol. Biochem. Behav. 40 1991 471 478
25. R. Mechoulam, L. Hanus, and E. Fride Towards cannabinoid drugs-revisited Prog. Med. Chem. 35 1998 199 243
26. L.A. Parker, R. Mechoulam, and C. Schlievert Cannabidiol, a non-psychoactive component of cannabis and its synthetic dimethylheptyl homolog suppress nausea in an experimental model with rats NeuroReport 13 2002 567 570
27. R.G. Pertwee Pharmacology of cannabinoid CB1 and CB2 receptors Pharmacol. Ther. 74 1997 129 180
28. R.G. Pertwee Cannabinoids and the gastrointestinal tract Gut 48 2001 859 867
29. L. Pinto, R. Capasso, G. Di Carlo, and A.A. Izzo Endocannabinoids and the gut Prostaglandins Leukot. Essent. Fat. Acids 66 2002 333 341
30. M.H. Rhee, Z. Vogel, J. Barg, M. Bayewitch, R. Levy, L. Hanus, A. Breuer, and R. Mechoulam Cannabinol derivatives: binding to cannabinoid receptors and inhibition of adenylylcyclase J. Med. Chem. 40 1997 3228 3233
31. P. Robson Therapeutic aspects of cannabis and cannabinoids Br. J. Psychiatry 178 2001 107 115
32. A. Tjolsen, and K. Hole Animal models of analgesia L. Dickenson J. Bessing The Pharmacology of Pain 1997 Springer Heidelberg 1 20
33. A. Tjolsen, O.G. Berge, S. Hunskaar, J.H. Rosland, and K. Hole The formalin test: an evaluation of the method Pain 51 1992 5 17
34. L. Walter, A. Franklin, A. Witting, C. Wade, Y. Xie, G. Kunos, K. Mackie, and N. Stella Nonpsychotropic cannabinoid receptors regulate microglial cell migration J. Neurosci. 23 2003 1398 1405
35. J.M. Young, D.A. Spires, C.J. Bedord, B. Wagner, S.J. Ballaron, and L.M. De Young The mouse ear inflammatory response to topical arachidonic acid J. Invest. Dermatol. 82 1984 367 371